Celtic Pharma Holdings Advisors Llp

POWER SEARCH PRICING

SOLUTIONS

celtic pharma holdings advisors llp Company Information

Company Number

OC336567

Next Accounts

Dec 2025

Directors

Richard Garraway

George Iliffe

View All

Shareholders

Group Structure

View All

Industry

Registered Address

21-27 lambs conduit street, london, WC1N 3GS

Website

www.celticpharmaholdings.com

celtic pharma holdings advisors llp Estimated Valuation

£0

Pomanda estimates the enterprise value of CELTIC PHARMA HOLDINGS ADVISORS LLP at £0 based on a Turnover of £0 and 0x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Celtic Pharma Holdings Advisors Llp is a live company located in london, WC1N 3GS with a Companies House number of OC336567. Founded in April 2008, it's largest shareholder is unknown. Celtic Pharma Holdings Advisors Llp is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

There is insufficient data available to calculate a health check for Celtic Pharma Holdings Advisors Llp. Company Health Check FAQs

Health Rating0out of 5

0 Strong

0 Regular

0 Weak

Size

There is insufficient data available for this Key Performance Indicator!

Growth

There is insufficient data available for this Key Performance Indicator!

EXPORT

Celtic Pharma Holdings Advisors Llp's latest turnover from March 2024 is estimated at 0 and the company has net assets of £76. According to their latest financial statements, we estimate that Celtic Pharma Holdings Advisors Llp has no employees and maintains cash reserves of £76 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	0	0	0	10,298	19,513	0	381,693	381,693	679,931	850,949	558,287	1,270,328	1,342,556	2,157,265	1,182,613
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	10,298	19,513	0	381,693	381,693	679,931	850,949	0	0	0	0	0
Admin Expenses	4	3	3	-5,211	-15,505	-139,415	58,649	38,570	82,688	122,229	-81,556	-632,639	-289,872	-619,134	-51,214
Operating Profit	-4	-3	-3	15,509	35,018	139,415	323,044	343,123	597,243	728,720	81,556	632,639	289,872	619,134	51,214
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	19	0
Interest Receivable	4	3	3	0	0	0	7	282	144	63	272	430	643	49,115	342
Pre-Tax Profit	0	0	0	-4,361	-142,502	139,415	58,051	297,420	597,387	728,783	81,828	633,069	290,515	668,230	51,556
Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Tax	0	0	0	-4,361	-142,502	139,415	58,051	297,420	597,387	728,783	81,828	633,069	290,515	668,230	51,556
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	0	0	0	-4,361	-142,502	139,415	58,051	297,420	597,387	728,783	81,828	633,069	290,515	668,230	51,556
Employee Costs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Number Of Employees	0	0	0	0	0	0	0	0	0	0	0	0	4	4	4
EBITDA*	-4	-3	-3	15,509	35,018	139,415	323,044	348,306	605,961	737,817	88,022	637,623	303,976	635,823	66,385

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	0	0	0	0	0	0	1	1	5,184	13,902	22,999	11,538	3,115	17,219	33,908
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	0	0	0	0	0	0	1	1	5,184	13,902	22,999	11,538	3,115	17,219	33,908
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	0	0	0	0	0	0	541	541	541	5,145	7,118	1,500,038	125,685	23,942	10,215
Group Debtors	0	0	0	0	550	550	550	281,338	163,688	111,936	163,368	107,453	28,401	130,241	530,928
Misc Debtors	0	0	0	53	655	1,038	12,584	1,401	394,149	1,045,932	373,255	262,623	644,910	233,908	24,871
Cash	76	76	76	709	14,089	135,190	122,739	475,364	33,402	121,817	633,579	401,734	1,368,597	1,879,576	780,228
misc current assets	0	0	0	0	19,870	197,390	197,390	301,910	0	0	0	0	0	0	0
total current assets	76	76	76	762	35,164	334,168	333,804	1,060,554	591,780	1,284,830	1,177,320	2,271,848	2,167,593	2,267,667	1,346,242
total assets	76	76	76	762	35,164	334,168	333,805	1,060,555	596,964	1,298,732	1,200,319	2,283,386	2,170,708	2,284,886	1,380,150
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	0	0	0	0	11,356	11,319	11,679	42,528	17,875	2,043	74,617	5,704	86,985	32,751	764
Group/Directors Accounts	0	0	0	4,729	4,290	62,382	40,416	12,675	20,153	395	0	0	0	101,886	63,294
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	0	0	0	0	19,124	67,571	8,229	389,922	10,813	315,558	673,297	1,426,550	1,801,177	1,833,671	1,232,772
total current liabilities	0	0	0	4,729	34,770	141,272	60,324	445,125	48,841	317,996	747,914	1,432,254	1,888,162	1,968,308	1,296,830
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	50,000	270,000	270,000	250,000	230,000	210,000	190,000	0	0	0
total long term liabilities	0	0	0	0	0	50,000	270,000	270,000	250,000	230,000	210,000	190,000	0	0	0
total liabilities	0	0	0	4,729	34,770	191,272	330,324	715,125	298,841	547,996	957,914	1,622,254	1,888,162	1,968,308	1,296,830
net assets	76	76	76	-3,967	394	142,896	3,481	345,430	298,123	750,736	242,405	661,132	282,546	316,578	83,320
total shareholders funds	76	76	76	-3,967	394	142,896	3,481	345,430	298,123	750,736	242,405	661,132	282,546	316,578	83,320

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-4	-3	-3	15,509	35,018	139,415	323,044	343,123	597,243	728,720	81,556	632,639	289,872	619,134	51,214
Depreciation	0	0	0	0	0	0	0	5,183	8,718	9,097	6,466	4,984	14,104	16,689	15,171
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors	0	0	-53	-1,152	-383	-12,087	-269,605	-275,098	-604,635	619,272	-1,326,373	1,071,118	410,905	-177,923	566,014
Creditors	0	0	0	-11,356	37	-360	-30,849	24,653	15,832	-72,574	68,913	-81,281	54,234	31,987	764
Accruals and Deferred Income	0	0	0	-19,124	-48,447	59,342	-381,693	379,109	-304,745	-357,739	-753,253	-374,627	-32,494	600,899	1,232,772
Deferred Taxes & Provisions	0	0	0	0	-50,000	-220,000	0	20,000	20,000	20,000	20,000	190,000	0	0	0
Cash flow from operations	-4	-3	50	-13,819	-63,009	-9,516	180,107	1,047,166	941,683	-291,768	750,055	-699,403	-85,189	1,446,632	733,907
Investing Activities
capital expenditure	0	0	0	0	0	1	0	0	0	0	-17,927	-13,407	0	0	-18,236
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	0	0	0	0	0	1	0	0	0	0	-17,927	-13,407	0	0	-18,236
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	-4,729	439	-58,092	21,966	27,741	-7,478	19,758	395	0	0	-101,886	38,592	63,294
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	4,043	0	0	0	-400,000	-250,113	-1,050,000	-220,452	-500,555	-254,483	-324,547	-434,972	31,764
interest	4	3	3	0	0	0	7	282	144	63	272	430	643	49,096	342
cash flow from financing	4	3	-683	439	-58,092	21,966	-372,252	-257,309	-1,030,098	-219,994	-500,283	-254,053	-425,790	-347,284	95,400
cash and cash equivalents
cash	0	0	-633	-13,380	-121,101	12,451	-352,625	441,962	-88,415	-511,762	231,845	-966,863	-510,979	1,099,348	780,228
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	0	0	-633	-13,380	-121,101	12,451	-352,625	441,962	-88,415	-511,762	231,845	-966,863	-510,979	1,099,348	780,228

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for celtic pharma holdings advisors llp. Get real-time insights into celtic pharma holdings advisors llp's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for celtic pharma holdings advisors llp by selecting its closest rivals, whether from the industry sector, other established companies, companies in WC1N area or any other competitors across 12 key performance metrics.

CELTIC PHARMA HOLDINGS ADVISORS LLP group structure

Celtic Pharma Holdings Advisors Llp has no subsidiary companies.

Ultimate parent company

CELTIC PHARMA HOLDINGS ADVISORS LLP

OC336567

CELTIC PHARMA HOLDINGS ADVISORS LLP Shareholders

Celtic Pharma Holdings Advisors Llp currently has 20 directors. The longest serving directors include Dr Richard Garraway (Apr 2008) and Mr George Iliffe (Apr 2008).

officer	country	age	start	end	role
Dr Richard Garraway	England	59 years	Apr 2008	-	LLP Member
Mr George Iliffe	United Kingdom	54 years	Apr 2008	-	LLP Designated Member
Mr Richard Garraway		59 years	Apr 2008	-	LLP Member
Mr John Mayo		68 years	Jan 2023	-	LLP Designated Member
Mr David Quint		74 years	Jan 2023	-	LLP Member
Ms Lorraine Bermingham	England	54 years	Jan 2023	-	LLP Member
Mr Fredrik Ljungstrom	England	65 years	Jan 2023	-	LLP Member
Ms Linda Summerton	England	62 years	Jan 2023	-	LLP Member
Mr Ali Baruni		77 years	Jan 2023	-	LLP Member
Ms Karen Frost	England	52 years	Jan 2023	-	LLP Member

P&L

March 2024

turnover

operating profit

-4

gross margin

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

total assets

cash

net assets

Total assets minus all liabilities

Similar Companies

Similar companies unavailable for this selection

company number

OC336567

Type

Other

industry

incorporation date

April 2008

ultimate parent company

None

previous names

N/A

address

21-27 lambs conduit street, london, WC1N 3GS

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to celtic pharma holdings advisors llp. Currently there are 2 open charges and 0 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for CELTIC PHARMA HOLDINGS ADVISORS LLP. This can take several minutes, an email will notify you when this has completed.

celtic pharma holdings advisors llp Company Information

celtic pharma holdings advisors llp Estimated Valuation

celtic pharma holdings advisors llp Estimated Valuation

celtic pharma holdings advisors llp Estimated Valuation

Celtic Pharma Holdings Advisors Llp Overview

Celtic Pharma Holdings Advisors Llp Health Check

CELTIC PHARMA HOLDINGS ADVISORS LLP financials

celtic pharma holdings advisors llp Credit Report and Business Information

Celtic Pharma Holdings Advisors Llp Competitor Analysis

celtic pharma holdings advisors llp Ownership

celtic pharma holdings advisors llp directors

celtic pharma holdings advisors llp company details

celtic pharma holdings advisors llp Charges & Mortgages

celtic pharma holdings advisors llp Capital Raised & Share Issues BETA

celtic pharma holdings advisors llp Companies House Filings - See Documents